Christopher Brede
Urology · Grand Rapids, MINPI 1093958621
Payments from drug & device makers
What this record shows
This record is dominated by education: $11,792 of the $14,289 with a category attached, or 82.5%. Intuitive Surgical accounts for 99.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $8,758 and has fallen 99.8% since, to $17 in 2025.
Across 33 payments — averaging $432.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Myovant Sciences Inc.$24
- Ferring Pharmaceuticals Inc.$17
- AbbVie$16
- E.r. Squibb & Sons, L.L.C.$16
- Pfizer$14
- plus $2 from 1 others
Across 43 payments — averaging $1242.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$53K
What the payments were for
- Travel & lodging$1,89613%
- Food & beverage$6004%
- Education$11,79283%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 27 | $14,199 |
| Myovant Sciences Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| AbbVie | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Pfizer | 1 | $14 |
| Travere Therapeutics, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$10,915
- DA VINCI SP$3,000
How this compares
$14,289 in reported general payments places this provider in the 85th percentile of 400 urology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 22 | $24,350 |
| Tamsulosin Hcl | 122 | $2,439 |
| Finasteride | 83 | $1,292 |
| Ciprofloxacin Hcl | 34 | $112 |
| Amoxicillin | 14 | $29 |
Paid to pharmacies, not to this prescriber.
Other urology in Grand Rapids
- Phillip WiseGrand Rapids$28K
- John AnemaGrand Rapids$24K
- George GhareebGrand Rapids$16K
- Ashok ReddySterling Heights$4.9M
- William RobertsAnn Arbor$973K
- Kenneth KernenTroy$910K
- William JohnstonLivonia$675K
- Jason HafronWest Bloomfield$490K
- Khurshid GhaniAnn Arbor$413K
- Richard BennettRoyal Oak$361K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.